Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Catheterization
  • Catheters, Indwelling
  • Wound Healing

abstract

  • The risk of a wound dehiscence requiring chest wall port explant in patients treated with bevacizumab was inversely proportional to the interval between bevacizumab administration and port placement, with significantly higher risk seen when the interval is less than 14 days.

publication date

  • March 15, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5103619

Digital Object Identifier (DOI)

  • 10.1002/cncr.25573

PubMed ID

  • 21381016

Additional Document Info

start page

  • 1296

end page

  • 301

volume

  • 117

number

  • 6